During Thursday’s after-market session, Immuron Limited (NASDAQ: IMRN) experienced a notable increase in share price after the news of its intention to pursue clinical studies.
Immuron Limited (NASDAQ: IMRN) experienced a rollercoaster ride in the stock market, with a surprising surge followed by a significant dip. Yesterday, IMRN plummeted by
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.